INFO & BLOG
About diagnosis, treatment and recovery
How and who decides on my ovarian cancer treatment?
The decision belongs to the multidisciplinary oncology board, not one physician; tumor type, stage and molecular profile are evaluated to plan treatment and sequence.
Do I have surgery first or chemotherapy first?
It depends on stage and extent; in advanced cases neoadjuvant chemotherapy followed by interval surgery may be preferred, with the sequence set by the board.
What is cytoreductive (debulking) surgery and why does it matter?
It is the most complete possible removal of tumor spread within the abdomen; leaving as little tumor as possible matters, making surgeon experience decisive.
Is HIPEC applied to every patient?
No; HIPEC is applied only in selected cases during cytoreductive surgery, and the board decides on its suitability.
What does the CA-125 value indicate?
CA-125 is a tumor marker aiding diagnosis, treatment response and follow-up; alone it does not confirm diagnosis and is read with other findings.
Why is BRCA testing important and who is suitable for PARP inhibitors?
In suitable patients with a BRCA mutation or homologous recombination deficiency, PARP inhibitor maintenance may delay recurrence; the result also informs family risk assessment.
Will treatment affect my fertility?
In early-stage, suitable cases fertility-preserving approaches may be considered; this is evaluated with the board based on tumor type and stage.
What documents should I have for a second opinion?
Your ultrasound/MRI/PET-CT images, CA-125 and other blood values, any pathology report and prior treatment summaries are sufficient for the board.
How is follow-up done after treatment?
You are monitored for recurrence with regular exams, CA-125 follow-up and imaging when needed; this can also continue remotely via tele-oncology.
I am coming from abroad; how does the process work?
Evaluation begins remotely with your file; after the board opinion and offer are shared, the process is planned with visa, transfer, accommodation and interpreter support.